378 related articles for article (PubMed ID: 9103686)
1. Acceptability and discontinuation of Depo-Provera, IUCD and combined pill in Kenya.
Sekadde-Kigondu C; Mwathe EG; Ruminjo JK; Nichols D; Katz K; Jessencky K; Liku J
East Afr Med J; 1996 Dec; 73(12):786-94. PubMed ID: 9103686
[TBL] [Abstract][Full Text] [Related]
2. Comparative acceptability of combined and progestin-only injectable contraceptives in Kenya.
Ruminjo JK; Sekadde-Kigondu CB; Karanja JG; Rivera R; Nasution M; Nutley T
Contraception; 2005 Aug; 72(2):138-45. PubMed ID: 16022854
[TBL] [Abstract][Full Text] [Related]
3. Acceptability study of the two versus three monthly injectable contraceptives.
Aly FA; El-genedi MM; Toppozada HK; El-abd M; Loutfi I
Dirasat Sukkaniyah; 1984; 11(69):27-39. PubMed ID: 12179796
[TBL] [Abstract][Full Text] [Related]
4. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
5. The effect of low-oestrogen combined pill, progestogen-only pill and medroxyprogesterone acetate on oral glucose tolerance test.
Kamau RK; Maina FW; Kigondu C; Mati JK
East Afr Med J; 1990 Aug; 67(8):550-5. PubMed ID: 2148146
[TBL] [Abstract][Full Text] [Related]
6. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception.
Cromer BA; Smith RD; Blair JM; Dwyer J; Brown RT
Pediatrics; 1994 Nov; 94(5):687-94. PubMed ID: 7936897
[TBL] [Abstract][Full Text] [Related]
7. Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant.
Harel Z; Biro FM; Kollar LM; Rauh JL
J Adolesc Health; 1996 Aug; 19(2):118-23. PubMed ID: 8863083
[TBL] [Abstract][Full Text] [Related]
8. Depo-Provera in adolescents: effects of early second injection or prior oral contraception.
Harel Z; Biro FM; Kollar LM
J Adolesc Health; 1995 May; 16(5):379-84. PubMed ID: 7662688
[TBL] [Abstract][Full Text] [Related]
9. Utilisation of family planning services at the teaching hospital in Blantyre, Malawi.
Lema VM; Mtimavalye LA; Gondwe EE
East Afr Med J; 1994 Nov; 71(11):703-11. PubMed ID: 7859653
[TBL] [Abstract][Full Text] [Related]
10. [The end of IUD marketing in the United States: what does it mean for American women?].
Forrest JD
Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives.
Moore LL; Valuck R; McDougall C; Fink W
Contraception; 1995 Oct; 52(4):215-9. PubMed ID: 8605778
[TBL] [Abstract][Full Text] [Related]
12. [Attitudes towards contraception and some reasons for discontinuation].
Lodewijckx E
Contracept Fertil Sex (Paris); 1987 Nov; 15(11):1025-30. PubMed ID: 12341566
[TBL] [Abstract][Full Text] [Related]
13. Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents.
Polaneczky M; Liblanc M
J Adolesc Health; 1998 Aug; 23(2):81-8. PubMed ID: 9714170
[TBL] [Abstract][Full Text] [Related]
14. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
Cromer BA; Blair JM; Mahan JD; Zibners L; Naumovski Z
J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
[TBL] [Abstract][Full Text] [Related]
15. Continuation of injectable contraceptives in Thailand.
Narkavonnakit T; Bennett T; Balakrishnan TR
Stud Fam Plann; 1982 Apr; 13(4):99-105. PubMed ID: 6216633
[TBL] [Abstract][Full Text] [Related]
16. Satisfaction with and intention to continue Depo-Provera versus the Mirena IUD among post-partum adolescents through 12 months of follow-up.
Howard DL; Wayman R; Strickland JL
J Pediatr Adolesc Gynecol; 2013 Dec; 26(6):358-65. PubMed ID: 24238267
[TBL] [Abstract][Full Text] [Related]
17. The use of depot medroxyprogesterone acetate (DMPA) injectable contraceptive in Enugu, Nigeria.
Hu E; Ikeako LC; Obiora-Okafor NC
Niger J Med; 2012; 21(3):266-71. PubMed ID: 23304918
[TBL] [Abstract][Full Text] [Related]
18. Effect of Depo-Provera or Microgynon on the painful crises of sickle cell anemia patients.
de Abood M; de Castillo Z; Guerrero F; Espino M; Austin KL
Contraception; 1997 Nov; 56(5):313-6. PubMed ID: 9437560
[TBL] [Abstract][Full Text] [Related]
19. Introducing more contraceptive methods in Jordan.
Gallagher M
AVSC News; 1998; 36(1):3, 8. PubMed ID: 12321883
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of contraceptive acceptors in Luanda, Angola.
Carvalho A; Laudari C; Marini M; Faundes A
Afr J Fertil Sexual Reprod Heal; 1996 Dec; 1(2):109-14. PubMed ID: 12321195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
